NCT05670028View on ClinicalTrials.gov

Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 4, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

June 4, 2026

Conditions
Ischemic StrokeRevascularizationBlood PressureCerebrovascular InsufficiencyCerebral AutoregulationIndividuationHemorrhagic Transformation Due to Acute Stroke
Interventions
DRUG

Hypotensive Drugs and/or Vasoactive Drugs

To manipulate the blood pressure within a certain range with hypotensive drugs (e.g. nifedipine, benidipine, captopril, benazepril, irbesartan, labetalol, urapidil) and/or vasoactive drugs (noradrenaline or dopamine).

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER